Ritocom (Lopinavir + Ritonavir)

Lopinavir and Ritonavir combination therapy represents a potent antiretroviral solution designed to manage HIV infection effectively. This dual-action protease inhibitor works by blocking viral enzymes, slowing disease progression and helping restore immune function.

Typically administered at prescribed dosages determined by healthcare providers based on individual patient profiles, this medication requires consistent adherence for optimal results.

Common side effects may include gastrointestinal discomfort, nausea, diarrhea, and elevated cholesterol levels, though many patients tolerate treatment well with proper monitoring. When taken as directed alongside other antiretroviral agents, this combination therapy can significantly improve viral suppression and quality of life.

Consult your healthcare provider regarding appropriate dosing schedules, potential drug interactions, and personalized management strategies to maximize therapeutic benefits while minimizing adverse effects.